Impact of universal masking in reducing the risk of nosocomial respiratory viruses among people with cancer
Infection Control & Hospital Epidemiology · 2024
DOI: 10.1017/ice.2024.144 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2024. Verfasst von Judy Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Hauptthemen laut MEDLINE: Cross Infection, Masks, Neoplasms, Respiratory Tract Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Universal masking within healthcare settings was adopted to combat the spread of coronavirus disease 2019 (COVID-19). In addition to mitigating the risk for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, it also had an added benefit of preventing the nosocomial transmission of other respiratory viral diseases.
Objective
This study examines the impact of the masking intervention on nosocomial respiratory viral infections (RVI) in vulnerable sub-populations of people with cancer at a tertiary care hospital.
Design
Interrupted time series analysis.
Methods
We reviewed non-SARS-CoV-2 nosocomial RVI between January 1, 2017 and December 31, 2023 and compared its quarterly trends before (January 2017 to March 2020) and after (April 2020 to December 2023) the universal masking intervention was implemented.
Results
Prior to the masking policy, there was no significant change in the quarterly rate of non-SARS-CoV-2 nosocomial RVI (baseline trend: P = 0.662). Crude infection rates decreased from 5.6% preintervention to 4.3% after the masking policy was implemented ( P < 0.001). Quarterly trends continued to steadily decline post-intervention ( β = −0.10, SE = 0.04, P < 0.007).
Conclusions
Our results suggest that universal face masking is associated with reduced non-SARS-CoV-2 nosocomial RVI, providing further evidence to support the continued use of face masks in healthcare settings to protect the health of immunocompromised patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Infection Control, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Department of Medicine, Joan and Sanford Weill Medical College of Cornell University, New York, NY, USA.
ORCID-Profile: Judy Yan, Tara McClure, Tania Bubb, Shauna Usiak
Förderung
- NCI NIH HHS
Zitieren
APA
Yan, J., McClure, T., Aslam, A., Bubb, T., Babady, N. E., Usiak, S., & Kamboj, M. (2024). Impact of universal masking in reducing the risk of nosocomial respiratory viruses among people with cancer. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2024.144
Vancouver
Yan J, McClure T, Aslam A, Bubb T, Babady NE, Usiak S, et al. Impact of universal masking in reducing the risk of nosocomial respiratory viruses among people with cancer. Infection Control & Hospital Epidemiology. 2024. doi:10.1017/ice.2024.144
BibTeX
@article{Yan2024,
author = {Yan, Judy and McClure, Tara and Aslam, Anoshé and Bubb, Tania and Babady, N Esther and Usiak, Shauna and Kamboj, Mini},
title = {Impact of universal masking in reducing the risk of nosocomial respiratory viruses among people with cancer},
journal = {Infection Control & Hospital Epidemiology},
year = {2024},
doi = {10.1017/ice.2024.144}
}
EUVIMED